We have now completed a $150,000 grant with Calgary based SAIT, which build on the earlier work by Melbourne based Hydrix. The result is a more advanced design...
In October 2017 we were able to treat a severely ill asthmatic patient in Calgary ICU with our experimental S1226 drug. Results were in the words of the...
CALGARY, AB – December 6, 2016. SolAeroMed Inc. is excited to report a brand new investment opportunity. Please click here to find out more information about our new investment announcement for...
